Editor’s note: May is National Cancer Research Month, which provides an opportunity to highlight the incredible scientific and clinical research […]
READ MORE

All the way across the country from one another, two pancreatic cancer researchers made similar discoveries in their labs. Rushika […]
READ MORE

Pancreatic Cancer Action Network (PanCAN) research grantee Kenneth Olive, PhD, is dedicated to keeping his lab as connected as possible […]
READ MORE

New research suggests that pancreatic tumors can be classified into two broad categories – and this information can help guide […]
READ MORE

The goal of cancer treatment is to identify – and attack – vulnerabilities that make cancer cells different from healthy […]
READ MORE

We are extremely sad to share that Pancreatic Cancer Action Network (PanCAN) research grant recipient David Boothman, PhD, died on […]
READ MORE

When immunology expert Ingunn Stromnes, PhD, assistant professor of microbiology and immunology at the University of Minnesota, unexpectedly discovered a […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: May is National Cancer Research Month, and we recently had the opportunity to speak with two leading pancreatic […]
READ MORE

A study published in Nature today describes how mutant KRAS impacts pancreatic cancer cells’ ability to gather nutrients – and […]
READ MORE

Editor’s note: In this Washington Post article, Nathaniel Brooks Horwitz wrote about his experience launching biopharmaceutical company Nivien Therapeutics in […]
READ MORE

Editor’s note: Stephanie Dougan, PhD, is an immunologist at Dana-Farber Cancer Institute in Boston. She is also the recipient of […]
READ MORE

Editor’s note: Andrew Aguirre, MD, PhD, is an oncologist at Dana-Farber Cancer Institute in Boston, where he also heads a […]
READ MORE

Editor’s note: Michael Curran, PhD, is a 2018 Pancreatic Cancer Action Network (PanCAN) Translational Research Grant recipient. He is an […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

Editor’s note: On July 25, 2008, 10 years ago today, professor Randy Pausch, PhD, of “The Last Lecture” fame, died […]
READ MORE

If you had asked Jason Doles, PhD, five years ago where he anticipated he’d be today, he would not have […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

Not all heroes wear capes; some of them wear lab coats. And if Jennifer Wargo, MD, MMSc, were to gain superhero […]
READ MORE

Both Wantong Yao, MD, PhD, and Haoqiang Ying, MD, PhD, underwent medical training in China. They both became deeply interested […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

Editor’s note: This story was originally published in 2016, but we are sharing it again this month in celebration and […]
READ MORE

Changes that cause a normal cell to become cancerous are often genetic in nature – mutations or altered expression of […]
READ MORE

Even the name of the grant mechanism – Research Acceleration Network, or RAN – conveys speed. And that’s exactly what […]
READ MORE

From a young age, I knew that I wanted to be a doctor. During my freshman year of college, I […]
READ MORE

In the early 1980s, I was honored to be a part of the scientific team that discovered the Ras oncogene […]
READ MORE

My 2003 Career Development Award from the Pancreatic Cancer Action Network helped validate my decision to focus my scientific and […]
READ MORE

I have dedicated my nearly 30-year career to the diagnosis and treatment of cancer. Pancreatic cancer has historically stood out […]
READ MORE

Pancreatic cancer first came into my life when I was a 3rd year medical student working on the medicine wards. […]
READ MORE

My journey to pancreatic cancer research is an unusual one. In graduate school, I was trained in a DNA laboratory […]
READ MORE

My initial interest in cancer was purely academic. I was curious how genetic mutations would transform a normal cell and […]
READ MORE

One of the reasons that pancreatic cancer has been so notoriously difficult to treat is that it depends on a […]
READ MORE

I began my journey into cancer research by training under world-class physicians and scientists such as Steven A. Rosenberg, MD, […]
READ MORE

My interest in pancreatic cancer was sparked by the aggressiveness of the disease and the urgency of finding early detection […]
READ MORE

I am an Assistant Professor at the University of California, Los Angeles (UCLA), where I am a sub-specialty gastrointestinal pathologist […]
READ MORE

I learned a valuable lesson about this disease firsthand. In a weekly men’s group meeting  at my church, I watched […]
READ MORE

The most difficult part of tackling what seems to be an insurmountable problem is getting started. When I reflect on […]
READ MORE

I started to realize that cancer was a very serious word when I was a child. My mom was then […]
READ MORE

The first time I came face-to-face with pancreatic cancer, as a third year medical student, I had no idea how […]
READ MORE